( OTC-PINK:RXII, OTC-QB:RXII )

News from RXi Pharmaceuticals Corporation A wide array of domestic and global news stories; news topics include politics/government, business, technology, religion, sports/entertainment, science/nature, and health/lifestyle. Articles that appear in this section may be written in English or other languages.

Latest

20 Apr, 2017, 07:02 ET RXi Pharmaceuticals to Present an Update on its Consumer Product Development Programs at the Society for Investigative Dermatology 76th Annual Meeting

RXi Pharmaceuticals Corporation (NASDAQ: RXII), a clinical-stage RNAi company developing innovative therapeutics that address significant unmet...


18 Apr, 2017, 07:02 ET RXi Pharmaceuticals Announces New Chief Development Officer and Key Management Changes

RXi Pharmaceuticals Corporation (NASDAQ: RXII), a clinical-stage RNAi company developing innovative therapeutics that address significant unmet...


31 Mar, 2017, 07:02 ET RXi Pharmaceuticals to Present at the American Association for Cancer Research Annual Meeting

RXi Pharmaceuticals Corporation (NASDAQ: RXII), a clinical-stage RNAi company developing innovative therapeutics that address significant unmet...


30 Mar, 2017, 07:02 ET RXi Pharmaceuticals Reports Fourth Quarter and Year End 2016 Financial Results and Recent Corporate Highlights

RXi Pharmaceuticals Corporation (NASDAQ: RXII), a clinical-stage RNAi company developing innovative therapeutics that address significant unmet...


28 Mar, 2017, 07:02 ET RXi Pharmaceuticals Granted Patent in Japan for Lead Clinical Candidate RXI-109

RXi Pharmaceuticals Corporation (NASDAQ: RXII), a clinical-stage RNAi company developing innovative therapeutics that address significant unmet...


22 Mar, 2017, 07:02 ET RXi Pharmaceuticals to Present at the 5th Annual Cancer BioPartnering & Investment Forum

RXi Pharmaceuticals Corporation (NASDAQ: RXII), a clinical-stage RNAi company developing innovative therapeutics that address significant unmet...


21 Mar, 2017, 07:02 ET RXi Pharmaceuticals to Present at the 2nd Annual Oligonucleotide and Peptide Therapeutics Conference

RXi Pharmaceuticals Corporation (NASDAQ: RXII), a clinical-stage RNAi company developing innovative therapeutics that address significant unmet...


16 Mar, 2017, 07:02 ET RXi Pharmaceuticals to Webcast Fourth Quarter and Year End 2016 Financial Results on Thursday, March 30, 2017

RXi Pharmaceuticals Corporation (NASDAQ: RXII), a clinical-stage RNAi company developing innovative therapeutics that address significant unmet...


14 Feb, 2017, 07:02 ET RXi Pharmaceuticals Appoints Medical Oncology Expert, Dr. James Griffin, to Scientific Advisory Board

RXi Pharmaceuticals Corporation (NASDAQ: RXII), a clinical-stage RNAi company developing innovative therapeutics that address significant unmet...


08 Feb, 2017, 07:02 ET RXi Pharmaceuticals to Present at Leading Investor and Healthcare Conferences

RXi Pharmaceuticals Corporation (NASDAQ: RXII), a clinical-stage RNAi company developing innovative therapeutics that address significant unmet...


09 Jan, 2017, 07:02 ET RXi Pharmaceuticals Completes Acquisition of MirImmune Inc. and Appoints New Chief Business Officer

RXi Pharmaceuticals Corporation (NASDAQ: RXII), a clinical-stage RNAi company developing innovative therapeutics that address significant unmet...


26 Dec, 2016, 07:02 ET RXi Pharmaceuticals to Present at the 9th Annual Biotech Showcase™

RXi Pharmaceuticals Corporation (NASDAQ: RXII), a clinical-stage company developing innovative therapeutics that address significant unmet medical...


21 Dec, 2016, 09:53 ET RXi Pharmaceuticals Announces Closing of $11.5 Million Underwritten Public Offering and Full Exercise of Over-allotment Option

RXi Pharmaceuticals Corporation (NASDAQ: RXII), a clinical-stage company developing innovative therapeutics that address significant unmet medical...


16 Dec, 2016, 08:15 ET RXi Pharmaceuticals Announces Pricing of $10 Million Underwritten Public Offering

RXi Pharmaceuticals Corporation (NASDAQ: RXII), a clinical-stage company developing innovative therapeutics that address significant unmet...


13 Dec, 2016, 07:02 ET RXi Pharmaceuticals Provides Year End Update on its Business Development and Clinical Programs

RXi Pharmaceuticals Corporation (NASDAQ: RXII), a clinical-stage company developing innovative therapeutics that address significant unmet medical...


10 Nov, 2016, 07:02 ET RXi Pharmaceuticals Reports Third Quarter 2016 Financial Results and Highlights Recent Corporate Developments

RXi Pharmaceuticals Corporation (NASDAQ: RXII), a clinical-stage company developing innovative therapeutics that address significant unmet medical...


27 Oct, 2016, 07:02 ET RXi Pharmaceuticals to Webcast Third Quarter 2016 Financial Results on Thursday, November 10, 2016

RXi Pharmaceuticals Corporation (NASDAQ: RXII), a clinical-stage RNAi company developing innovative therapeutics that address significant unmet...


12 Oct, 2016, 07:05 ET RXi Pharmaceuticals Plans to Conduct Securities Offering

RXi Pharmaceuticals Corporation (NASDAQ: RXII) announced today that it plans to conduct a securities offering in the near future. RXi plans...


12 Oct, 2016, 07:02 ET RXi Pharmaceuticals Enters into Exclusive Option Agreement to Acquire MirImmune Inc.

RXi Pharmaceuticals Corporation (NASDAQ: RXII), a clinical-stage RNAi company developing innovative therapeutics that address significant unmet...


11 Oct, 2016, 07:02 ET RXi Pharmaceuticals to Present at the 15th Annual BIO Investor Forum

RXi Pharmaceuticals Corporation (NASDAQ: RXII), a clinical-stage RNAi company developing innovative therapeutics that address significant unmet...


19 Sep, 2016, 07:02 ET RXi Pharmaceuticals to Present at the 16th Annual Biotech in Europe Forum for Global Partnering and Investment Conference

 RXi Pharmaceuticals Corporation (NASDAQ: RXII), a clinical-stage RNAi company developing innovative therapeutics that address significant...


12 Sep, 2016, 07:02 ET RXi Pharmaceuticals to Present at the 4th Targeting Ocular Disorders Conference

 RXi Pharmaceuticals Corporation (NASDAQ: RXII), a clinical-stage RNAi company developing innovative therapeutics that address significant...


07 Sep, 2016, 07:02 ET RXi Pharmaceuticals Corporation Selected to Present at Cavendish Global Health Impact Forum

RXi Pharmaceuticals Corporation (NASDAQ: RXII), a clinical-stage RNAi company developing innovative therapeutics that address significant unmet...


06 Sep, 2016, 07:02 ET RXi Pharmaceuticals to Present at the 9th Annual BioPharm America™ Conference

 RXi Pharmaceuticals Corporation (NASDAQ: RXII), a clinical-stage RNAi company developing innovative therapeutics that address significant...


11 Aug, 2016, 07:02 ET RXi Pharmaceuticals Reports Second Quarter 2016 Financial Results and Highlights Recent Corporate Developments

RXi Pharmaceuticals Corporation (NASDAQ: RXII), a clinical-stage RNAi company developing innovative therapeutics that address significant unmet...